Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, and Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 Central Lab Market – Scope of Report TMR’s report on the global central lab market studies the past as well as the ... Read More
-
Global Clinical Trial Kits Market 2022-2028
... or treatments are both safe and effective. The global clinical trial kits market is expected to increase by USD 327 million, at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2028, according ... Read More
-
Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Regulatory Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Regulatory Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology ... Read More
-
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update"" provides an overview of Diastolic Heart Failure Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
... food. While any food can cause an adverse reaction, eight types of food allergens account for about 90% of all reactions: eggs, milk, peanuts, tree nuts, fish, shellfish, wheat, and soybeans. Food-induced allergic disorders are ... Read More
-
Leading Clinical Trial Supplies Clinical Phase Markets Databank
... from 2021 to 2029. Phase III segment is expected to be the highest contributor to this market, with $771.8 Million in 2020, and is anticipated to reach $1,486.6 Million by 2029, registering a CAGR of ... Read More
-
Latin America, Middle East & Africa Clinical Trial Supplies Market Databank
... CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a ... Read More
-
Leading Clinical Trial Supplies Country Markets Databank
... 2021 to 2029. Europe is expected to be the highest contributor to this market, with $779.6 Million in 2020, and is anticipated to reach $1,530.3 Million by 2029, registering a CAGR of 7.82%. Asia-Pacific is ... Read More
-
North America Clinical Trial Supplies Market Databank
... 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical ... Read More
-
Europe Clinical Trial Supplies Market Databank
... to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device ... Read More
-
Leading Clinical Trial Supplies End Use Markets Databank
... from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. ... Read More
-
Asia-Pacific Clinical Trial Supplies Market Databank
... to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device ... Read More
-
Global Clinical Trial Supplies Market Databank
... to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device ... Read More
-
Pharmaceutical and Healthcare Industry in Russia - Forecast and Analysis 2022
... recent years. The country has made considerable progress in managing the COVID-19 pandemic and even released the first-ever vaccine to protect its population against the novel coronavirus infection. With the ongoing Russia-Ukraine war, there has ... Read More
-
Meniere Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Meniere Disease (Ear Nose Throat Disorders) pipeline landscape. Meniere disease is a disorder of the inner ear that causes ... Read More
-
T-Cell Lymphomas Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
... non-Hodgkin lymphomas (NHL), representing less than 15% of NHL in the US. The most important clinical distinction is made in separating primary cutaneous TCLs (CTCL), which affect primarily the skin, from peripheral TCLs (PTCL), which ... Read More
-
Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is a sexually transmitted disease (STD) caused by Neisseria gonorrhoeae bacterium. It can infect both ... Read More
-
Gouty Arthritis (Gout) Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 30 million diagnosed prevalent cases of gout across 16 pharmaceutical markets The majority of marketed drugs for the treatment of gout fall into the enzyme inhibitor and receptor ... Read More
-
Insomnia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 730 million prevalent cases of insomnia across 16 pharmaceutical markets There are five leading marketed drugs for the treatment of insomnia, Eisai is a key player in the disease space ... Read More
-
Healthcare Contract Research Outsourcing Market (Service: Clinical Trial Service, Regulatory Services, Clinical Data Management & Biometrics, Medical Writing, Pharmacovigilance, Site Management Protocol, and Others; Therapeutic Area: Oncology/Hematology, CNS, CV/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Medical Devices, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Academic Institutes & Government Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Healthcare Contract Research Outsourcing Market ... Read More
-
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hypercholesterolemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes ... Read More
-
Sarcopenia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... 51 million cases of sarcopenia in the 16 countries covered in GlobalData’s epidemiology forecast for sarcopenia. There is no FDA approved marketed product for the treatment of sarcopenia. The sarcopenia pipeline consists of 41 pharmaceuticals ... Read More
-
Vulvovaginal Candidiasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Vulvovaginal Candidiasis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Triple-Negative Breast Cancer (TNBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Triple-Negative Breast Cancer (TNBC) Clinical trials scenario. This report provides top line data ... Read More
Research Assistance
